SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Mocha Jet, Drugdoctor, joseytheoutlawwales, lasers, John_Langston, IB_
Search This Board: 
Last Post: 7/26/2017 3:46:13 PM - Followers: 834 - Board type: Free - Posts Today: 59

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Confidential Treatment Order (ct Order) 07/12/2017 05:00:02 PM
ELTP News: Current Report Filing (8-k) 07/12/2017 04:02:10 PM
ELTP News: Current Report Filing (8-k) 07/07/2017 05:23:56 PM
ELTP News: Current Report Filing (8-k) 06/14/2017 05:08:53 PM
ELTP News: Annual Report (10-k) 06/14/2017 04:46:49 PM
PostSubject
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#247416  Sticky Note HERE is WHAT long term investors need to UNDERSTAND!!! Couch 03/21/17 06:12:24 PM
#236265  Sticky Note Elite Pharma: The company of firsts: namtae 12/14/16 12:32:00 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Admin [Dan] 02/23/16 09:32:46 PM
#266989   FDA Ad Com thumbs down on Intellipharmaceutics' oxycodone pte 07/26/17 04:44:01 PM
#266988   I suggest that those who continue to post pte 07/26/17 03:46:12 PM
#266985   Gee just like BK, .02 cent and the Couch 07/26/17 03:39:19 PM
#266984   Yeah SequesTOX was a huge filing FAILURE TOO! stockboy 07/26/17 03:26:20 PM
#266981   Purdue WAS big everywhere. Prescription opioid drug abuse Jimmy Joe 07/26/17 03:17:25 PM
#266980   That was mine, 4999 sell of a 20000 Liam00 07/26/17 03:16:06 PM
#266979   scottrade shows last trade 13:48 .12 SCHH 07/26/17 03:14:05 PM
#266978   How in the world can ANYONE predict one conix 07/26/17 03:04:00 PM
#266977   Totally agree . . I have seen this dubc 07/26/17 01:49:21 PM
#266976   Yes, Purdue is very big everywhere.. The problem namtae 07/26/17 01:46:51 PM
#266975   I wonder why the Chinese Co.(PuraCap/HumanWell) that owns NASDAQ2020 07/26/17 01:25:58 PM
#266974   Purdue Oxycontin big in China and NH $ELTP lasers 07/26/17 01:18:37 PM
#266973   That's how I feel too. BS Sifter 07/26/17 01:14:57 PM
#266972   Red eye guy.... nice to see you here. Jimmy Joe 07/26/17 12:56:57 PM
#266971   Indeed Bngo - getting generic Percocet approved for Couch 07/26/17 12:56:26 PM
#266970   I want 11s and 10s . . Dont be dubc 07/26/17 12:56:13 PM
#266968   My guess is the FDA will approve generic Bngo 07/26/17 12:53:40 PM
#266967   First filing was last Fall so start watching NASDAQ2020 07/26/17 12:44:37 PM
#266966   so what??? there is zero evidence of any dr_lowenstein 07/26/17 12:43:42 PM
#266965   There was a meeting between Puracap which controls NASDAQ2020 07/26/17 12:36:11 PM
#266964   Just more BS just like all the other stockboy 07/26/17 12:24:50 PM
#266963   so now the propaganda line is China since dr_lowenstein 07/26/17 12:20:04 PM
#266962   It wasn't the first meeting between friends and NASDAQ2020 07/26/17 12:06:00 PM
#266961   Gee and here Nasrat was discussing taking SequestOx Couch 07/26/17 11:52:35 AM
#266960   GEE and yet no BK, .02 cents yesterday Couch 07/26/17 11:50:34 AM
#266959   So sales in China boom must be working stockboy 07/26/17 11:50:12 AM
#266958   Nice find Lasers...Mahalo Nui Loa!! Makai63 07/26/17 11:40:26 AM
#266957   Does a dinner that nasRAT bought one time stockboy 07/26/17 11:37:31 AM
#266956   I do remember that I remember I was stockboy 07/26/17 11:26:08 AM
#266955   Chinese Pharma wine-ing and dining Elite Pharma. NASDAQ2020 07/26/17 11:23:47 AM
#266954   ELTP=SCAM Filing makes it hammerlocked WOW that's news stockboy 07/26/17 11:09:48 AM
#266953   REALLY when it's DEAD! LOL WOW I bet stockboy 07/26/17 11:08:23 AM
#266952   Elite will have a hammer lock on the NASDAQ2020 07/26/17 10:55:40 AM
#266951   Elite's Reformulated SequestOx ™ NASDAQ2020 07/26/17 10:52:40 AM
#266950   Total BS - tell me again now many Couch 07/26/17 10:51:02 AM
#266949   Gee facts are facts. Glad I didn't sell Couch 07/26/17 10:49:09 AM
#266948   Complete and utter NON-sense just like the only stockboy 07/26/17 10:46:00 AM
#266947   The $2.10 valuation was a joke then and Goodtimes93 07/26/17 10:42:15 AM
#266946   I remember when Elite traded at an almost namtae 07/26/17 10:28:03 AM
#266945   Elite dying a slow death... light vol, no namtae 07/26/17 10:25:29 AM
#266944   The charts say WHOOPSY on those shares bought conix 07/26/17 10:09:35 AM
#266940   China sales boom for painkiller at centre of lasers 07/26/17 08:19:25 AM
#266938   17 Pathways to DollarLand NASDAQ2020 07/26/17 07:46:56 AM
#266937   The chart says WHOOPSY on the .02 cent Couch 07/26/17 05:58:12 AM
#266936   Gee and hear I've been hearing the same Couch 07/26/17 05:56:32 AM
#266935   LMAO; GEE and still no "SOON" ,02 cent Couch 07/26/17 05:55:16 AM
#266934   LMAO- my .06, .07, .08, .09, .10 cent Couch 07/26/17 05:52:28 AM
#266933   Gee my .06, .07, .08, .09 and 10 Couch 07/26/17 05:49:52 AM
#266932   So we STILL have people expecting an approval Jimmy Joe 07/26/17 05:22:52 AM
#266930   The chart says the BS is no longer John_Langston 07/25/17 11:29:40 PM
PostSubject